- ma 16 november 2026
- di 17 november 2026
- wo 18 november 2026
- do 19 november 2026
The most important European congress in the field of protein and antibody engineering for therapeutic applications. This biological and medical event brings together international biotechnology scientists and pharmaceutical researchers to discuss the latest oncological treatments, immunotherapies, and biological production technologies.
Scientific breakthroughs in biopharmacy
The development of advanced biological medicines plays a crucial role in the modern fight against cancer and autoimmune diseases. For eighteen years, this high-quality scientific congress has provided an independent platform where top researchers share their most recent data. The central focus is on designing more effective therapeutic proteins that intervene more specifically in biological processes in the human body.
An in-depth and specialized program
The meeting offers an intensive program divided into various specific streams and shorter conferences. Participants can choose from technical sessions on antibody engineering, immuno-oncology, cell therapies, and expression systems. In addition to academic presentations, the event offers practical training and interactive roundtables where participants discuss complex laboratory challenges. At the accompanying poster exhibition, young academics showcase their latest research results to the industry experts present.
The target group of this biomedical summit
This scientific congress is specifically designed for molecular biologists, biochemists, immunologists, and pharmacologists affiliated with universities or pharmaceutical laboratories. Process engineers and quality managers from the biotechnology industry also derive great value from the meeting. It is the ideal place to initiate international research collaborations and accelerate the translation of fundamental research into clinical applications.
